Nasal Allergy Treatments
Current guidelines recommend intranasal corticosteroids and nasal
irrigation as first line therapies for AR and ARS. Additional
therapeutic options may involve intranasal or systemic antihistamine
treatments, leukotriene antagonists, systemic corticosteroids,
immunotherapy and biological therapies, as well as surgery. Table 2
summarises research findings from AR/ARS treatment studies which report
throat symptoms as primary or secondary treatment outcomes, as well as
relevant recommendations derived from consensus guidelines. In general,
this literature is sparse and challenging to identify, with dominant
consideration given to cough within the UACS context. Some data
indicates that patients with AR may benefit from additional adjunct
treatment strategies additional to intranasal corticosteroids in order
to maximally address additional throat complaints, including
antihistamines and leukotriene antagonists, though insufficient evidence
is identified to provide recommendations. The role of immunotherapy and
other novel allergy treatment strategies for this purpose remains
uncertain without research attention.